Debra Patt, MD, MPH, MBA, on the factors influencing cost in novel therapeutic interventions

Dr. Patt, Executive Vice President, Policy, Academic Programs, Strategic Initiatives, Texas Oncology, elaborates on the factors influencing cost in novel therapeutic interventions

interventions